Advancing inducible gene-inactivation systems to explore synthetic lethality. [PDF]
Sánta ÁT +7 more
europepmc +1 more source
An Inducible BRCA1 Expression System with In Vivo Applicability Uncovers Activity of the Combination of ATR and PARP Inhibitors to Overcome Therapy Resistance. [PDF]
Irving E +9 more
europepmc +1 more source
Unique perspectives about men's awareness of BRCA1/2 genetic testing in primary care. [PDF]
Andrews CS +4 more
europepmc +1 more source
A novel BRCA mutation classification system reveals differential responses to PARP inhibition and prognostic outcomes in epithelial ovarian cancer: a multicenter study. [PDF]
Liu Q +18 more
europepmc +1 more source
Frequency of Founder Mutations in <i>BRCA1</i> and <i>BRCA2</i> Genes in Hereditary Breast Cancers in Poland vs. Other Countries. [PDF]
Kulikowska B, Panasiuk B, Posmyk R.
europepmc +1 more source
Germline <i>BRCA</i> testing in routine clinical practice: a single-center experience. [PDF]
Nikolényi A +15 more
europepmc +1 more source
Challenging the extended phenotype: HRD-negative salivary gland carcinoma in a <i>BRCA1</i> founder-variant carrier, case report and literature review. [PDF]
Torres W +6 more
europepmc +1 more source
Transcription factor BRCA1 is associated with BMPR1B transcriptional activity in sheep ovarian granulosa cells. [PDF]
Abdurahman A +5 more
europepmc +1 more source
Tyrer-Cuzick Lifetime Risk Is Not Associated With Non-BRCA1/2 Pathogenic Variants for Breast Carcinoma. [PDF]
Rao D +10 more
europepmc +1 more source

